Oates Thomas W, Huynh-Ba Guy
Forum Implantol. 2012 Feb;8(2):7-14.
The goal of this review is to critically appraise the clinical evidence guiding our application of dental implant therapy relative to glycemic control for patients with diabetes. Our initial searches of the literature identified 129 publications relevant to both dental implants and diabetes. These were reduced to 17 clinical studies for inclusion. Reported implant failure rates in these 17 reports ranged from 0 to 14.3% for patients with diabetes. Unfortunately, the majority of these reports lacked sufficient information relative to glycemic control to allow the application of the findings toward clinical care. However, clinical evidence is emerging from several investigations that diabetes and glycemic control are important considerations that may require modifications to therapeutic protocols, but may not be contraindications to implant therapy in diabetes patients. Also, a potentially important role for implant therapy to support oral function in diabetes dietary management remains to be determined.
本综述的目的是严格评估指导我们将牙种植体治疗应用于糖尿病患者血糖控制的临床证据。我们最初对文献的检索确定了129篇与牙种植体和糖尿病均相关的出版物。这些文献被缩减至17项纳入的临床研究。在这17份报告中，糖尿病患者的种植体失败率报告范围为0至14.3%。遗憾的是，这些报告中的大多数缺乏与血糖控制相关的足够信息，无法将研究结果应用于临床护理。然而，多项调查正在产生临床证据，表明糖尿病和血糖控制是重要的考虑因素，可能需要对治疗方案进行调整，但可能并非糖尿病患者种植体治疗的禁忌证。此外，种植体治疗在糖尿病饮食管理中支持口腔功能的潜在重要作用仍有待确定。
